Texas
LATEST FROM BIOSPACE
Shares of Molecular Templates are up more than 52 percent in premarket trading after the company announced it has struck a deal with pharma giant Takeda Pharmaceuticals.
Shelly Goel to be Named a 2018 Davidson Fellow
Texas A&M has been chosen as the recipient of a five-year grant from the Vulnerable Rural Hospitals Assistance Program, funded by the Health Resources and Services Administration (HRSA), an agency of the U.S. Department of Health and Human Services.
Heralds a new strategy for fighting cancer: Drugs that target two genes at a time
Despite the changing landscape in biopharma, many companies are still recruiting. If you’re looking to make a career change, here are 12 biopharma companies hiring on BioSpace now.
Reata Pharmaceuticals has updated the timing of coming data announcements for two ongoing mid-stage trials for rare renal diseases.
The 28-year-old CEO of Ascendance Biomedical removed his trousers and injected himself at the BDYHAX conference in Texas.
The company is now waiting for the FDA to determine a path forward in resuming clinical studies.
A look at whether the new tax reform will really spur a M&A spending spree for drugmakers.
PRESS RELEASES